Delisting risk
MDxHealth
Molecular prostate-cancer tests for testing and treatment decisions.
$0.7000
After-hours close−0.02 (−2.87%)
At close$0.7207(−0.11%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 48.18%24.75M sharesInsiders 22.78%11.70M sharesOther 29.04%14.92M shares
Shares outstanding 51.36M · Float 41.57M · 80.9% free float
Institutions13F, as of Mar 31, 2026
51 holders · 24.75M shares · 9 new positions · 21 increased · 17 reduced · 14 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Bleichroeder LP | 7.38M | 14.36% | 0 | May 14, 2026 |
| Awm Investment Company, Inc. | 5.22M | 10.17% | 0 | May 15, 2026 |
| MVM Partners, LLC | 4.70M | 9.15% | 0 | May 15, 2026 |
| Perkins Capital Management Inc | 1.48M | 2.87% | +97.5K | Apr 23, 2026 |
| Samjo Management, LLC | 1.45M | 2.82% | +53.5K | May 15, 2026 |
| Mink Brook Asset Management LLC | 1.20M | 2.34% | +940.0K | Apr 1, 2026 |
| Millennium Management LLC | 544.7K | 1.06% | +427.9K | May 15, 2026 |
| Northern Trust Corp | 494.5K | 0.96% | −3.7K | May 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Bleichroeder LP | 33.20% | 31.65M | 13D | Aug 14, 2026 ↗ |
| Genomic Health, Inc. | 12.00% | 6.44M | 13G | Jan 16, 2026 ↗ |
| Laurence W. Lytton | 11.00% | 2.89M | 13G | Oct 4, 2024 ↗ |
| AWM Investment Company, Inc. | 10.30% | 4.88M | 13G | Feb 7, 2025 ↗ |
| Exact Sciences Corporationincl. Genomic Health, Inc. | 7.10% | 3.44M | 13G | Oct 4, 2024 ↗ |
| Lytton Laurence W | 6.40% | 3.16M | 13G | Nov 14, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| MVM Partners, LLC | director | 6.90M | 13.44% | Aug 17, 2026 |
| Eric Bednarski | director | 4.70M | 9.15% | Apr 13, 2026 |
| Michael McGarrity | director, officer: Chief Executive Officer | 95.0K | 0.18% | Apr 13, 2026 |
1 ten-percent owner holds 2.63M shares by Form 4, outside the officers-and-directors figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 13, 2026 | MVM Partners, LLCdirector | Purchase | 2,202,643 | $0.4540 | 6,903,100 |
CongressHouse and Senate disclosures
Not reported.